(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇 | CAS:142217-77-4 | 希恩思试剂-品类齐全、品质保障、配送及时、畅选无忧

中文名称:	(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇
英文名称:	(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
CAS.No:	142217-77-4	CAS 相关:
MDL No:
分子式:	C₃₂H₃₃N₅O₄
分子量:	551.64	密度:
熔点:		沸点:
储藏条件:
危险安全标识:

中文名称:

(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇

英文名称:

(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol

CAS.No:

142217-77-4

CAS 相关:

MDL No:

分子式:

C₃₂H₃₃N₅O₄

分子量:

551.64

密度:

熔点:

沸点:

储藏条件:

危险安全标识:

* 如果需要咨询更多不同包装的价格，请您联系客服为您查询报价。
* 订购成功后，将从离您最近的仓库发货，如果其中一个仓库中库存不足，我们将从另外一个仓库发货以减少交货时间。

中文名称：: (1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇

中文别名：: 恩替卡韦中间体N4;(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇;1-碘-1-(三氟甲氧基)四氟乙烷;恩替卡韦中间体-4;恩替卡韦-4;恩替卡韦中间体4;[1S-(1Α,2Β,3Α,5Β)]-5-[2-氨基-6-(苯甲;恩替卡韦中间体四;1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇

英文名称：: (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol

英文别名：: (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol;(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cydopentanol;Entecavir intermediate N4;Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-;Entecavir Intermediate IV;(1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol;Cyclopentanol,5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,[1S-(1a,2b,3a,5b)]- (9CI);(1S,2S,3S,5S)-5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-Cyclopentanol;entecavir-4;AK-3;CYC089;CYC088;C32H33N5O4;RW2435;CE0038;AM84384;(1S,2S,3S,5S)-5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(p;(1S,2S,3S,5S)-5-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol;(1S,2S,3S,5S)-5-(2-AMINO-6-(BENZYLOXY)-9H-PURIN-9-YL)-3-(BENZYLOXY)-2- (BENZYLOXYMETHYL)CYCLOPENTANOL;AKOS015896664;AC-5919;C72659;142217-77-4;SCHEMBL2519691;A807869;DTXSID90672073;CS-0156210;DS-12112;W-205568;(1S,2S,3S,5S)-5-[2-AMINO-6-(BENZYLOXY)PURIN-9-YL]-3-(BENZYLOXY)-2-[(BENZYLOXY)METHYL]CYCLOPENTAN-1-OL;(1S,2S,3S,5S)-5-[2-AMINO-6-(BENZYLOXY)PURIN-9-YL]-3-(BENZYLOXY)-2-[(BENZYLOXY)METHYL]CYCLOPENTAN-1-OL;(1S,2S,3S,5S)-5-[2-Amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol;(1S,2S,3S,5S)-5-[2-Amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol